Cargando…
Editorial Comment from Dr Kobayashi to Pathological complete response after nivolumab therapy following angiogenesis inhibitors in a patient with metastatic renal cell carcinoma
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609187/ https://www.ncbi.nlm.nih.gov/pubmed/33163930 http://dx.doi.org/10.1002/iju5.12225 |
| _version_ | 1783604975486631936 |
|---|---|
| author | Kobayashi, Takashi |
| author_facet | Kobayashi, Takashi |
| author_sort | Kobayashi, Takashi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7609187 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76091872020-11-06 Editorial Comment from Dr Kobayashi to Pathological complete response after nivolumab therapy following angiogenesis inhibitors in a patient with metastatic renal cell carcinoma Kobayashi, Takashi IJU Case Rep Editorial Comment John Wiley and Sons Inc. 2020-10-05 /pmc/articles/PMC7609187/ /pubmed/33163930 http://dx.doi.org/10.1002/iju5.12225 Text en © 2020 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of Japanese Urological Association This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Comment Kobayashi, Takashi Editorial Comment from Dr Kobayashi to Pathological complete response after nivolumab therapy following angiogenesis inhibitors in a patient with metastatic renal cell carcinoma |
| title | Editorial Comment from Dr Kobayashi to Pathological complete response after nivolumab therapy following angiogenesis inhibitors in a patient with metastatic renal cell carcinoma |
| title_full | Editorial Comment from Dr Kobayashi to Pathological complete response after nivolumab therapy following angiogenesis inhibitors in a patient with metastatic renal cell carcinoma |
| title_fullStr | Editorial Comment from Dr Kobayashi to Pathological complete response after nivolumab therapy following angiogenesis inhibitors in a patient with metastatic renal cell carcinoma |
| title_full_unstemmed | Editorial Comment from Dr Kobayashi to Pathological complete response after nivolumab therapy following angiogenesis inhibitors in a patient with metastatic renal cell carcinoma |
| title_short | Editorial Comment from Dr Kobayashi to Pathological complete response after nivolumab therapy following angiogenesis inhibitors in a patient with metastatic renal cell carcinoma |
| title_sort | editorial comment from dr kobayashi to pathological complete response after nivolumab therapy following angiogenesis inhibitors in a patient with metastatic renal cell carcinoma |
| topic | Editorial Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609187/ https://www.ncbi.nlm.nih.gov/pubmed/33163930 http://dx.doi.org/10.1002/iju5.12225 |
| work_keys_str_mv | AT kobayashitakashi editorialcommentfromdrkobayashitopathologicalcompleteresponseafternivolumabtherapyfollowingangiogenesisinhibitorsinapatientwithmetastaticrenalcellcarcinoma |